Covid-19 manufacturing roundup: Catalent gets the FDA's go-ahead on J&J shot; AstraZeneca taps a new contractor
The FDA has authorized an Indiana CDMO to produce and ship millions of doses of J&J’s Covid-19 vaccine.
Catalent Pharma tweeted the news and an …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
